UnitedHealth Group Incorporated $UNH Position Increased by The Manufacturers Life Insurance Company

Key Points

• The Manufacturers Life Insurance Company increased its stake in UnitedHealth Group by 2.4%, holding 2,190,191 shares valued at approximately $1.15 billion.
• Analysts have adjusted price targets for UnitedHealth Group, with Truist Financial lowering its target from $360 to $345, while the consensus rating remains a "Moderate Buy" with an average price target of $353.
• UnitedHealth Group declared a quarterly dividend of $2.21 per share, with an annualized yield of 2.9%, to be paid on September 23rd.

The Manufacturers Life Insurance Company raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,190,191 shares of the healthcare conglomerate's stock after purchasing an additional 52,097 shares during the quarter. UnitedHealth Group accounts for 1.1% of The Manufacturers Life Insurance Company's portfolio, making the stock its 8th largest position. The Manufacturers Life Insurance Company owned approximately 0.24% of UnitedHealth Group worth $1,147,113,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of UNH. GAMMA Investing LLC boosted its stake in shares of UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Nuveen LLC purchased a new stake in shares of UnitedHealth Group in the first quarter worth about $3,846,764,000. Vanguard Group Inc. boosted its stake in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP boosted its position in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on UNH shares. KeyCorp lowered their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Bank of America increased their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Morgan Stanley decreased their target price on UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 20th. Finally, TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a research report on Monday, May 19th. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $353.00.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

UNH stock traded up $7.48 during trading on Friday, hitting $309.77. The company had a trading volume of 12,018,847 shares, compared to its average volume of 20,287,358. The firm has a market cap of $280.55 billion, a PE ratio of 13.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.43. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a 50-day moving average price of $288.16 and a 200-day moving average price of $380.68. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's quarterly revenue was up 12.9% on a year-over-year basis. During the same period last year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.